Benjamin Edwards’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.84M Sell
3,519
-453
-11% -$248K 0.02% 602
2026
Q2
$2.09M Sell
3,972
-289
-7% -$162K 0.02% 561
2026
Q1
$2.39M Sell
4,261
-194
-4% -$124K 0.02% 491
2025
Q4
$3.01M Buy
4,455
+10
+0.2% +$6.81K 0.03% 410
2025
Q3
$2.84M Buy
4,445
+358
+9% +$217K 0.03% 422
2025
Q2
$2.19M Buy
4,087
+311
+8% +$149K 0.03% 439
2025
Q1
$1.59M Buy
3,776
+439
+13% +$191K 0.02% 475
2024
Q4
$1.38M Buy
3,337
+1,457
+78% +$639K 0.02% 519
2024
Q3
$950K Buy
1,880
+1,633
+661% +$793K 0.01% 613
2024
Q2
$120K Sell
247
-22
-8% -$11K 0.02% 403
2024
Q1
$145K Buy
269
+10
+4% +$5.46K 0.03% 377
2023
Q4
$144K Hold
259
– – 0.03% 375
2023
Q3
$113K Hold
259
– – 0.03% 373
2023
Q2
$130K Sell
259
-26
-9% -$12.5K 0.03% 346
2023
Q1
$143K Buy
285
+36
+14% +$17.2K 0.03% 323
2022
Q4
$102K Buy
249
+32
+15% +$12.4K 0.03% 347
2022
Q3
$71K Buy
217
+7
+3% +$2.57K 0.02% 385
2022
Q2
$74K Buy
210
+59
+39% +$24.1K 0.02% 383
2022
Q1
$83K Buy
151
+150
+15,000% +$78.9K 0.02% 389
2021
Q4
$1K Buy
+1
New +$628 ﹤0.01% 696

Other funds holding IDXX

Benjamin Edwards's IDXX Position: Q3 2026 in Review

Benjamin Edwards reduced its Idexx Laboratories (IDXX) stake by 11% in Q3 2026, selling an estimated $248K and leaving 3,519 shares worth $1.84M. The position accounts for 0.02% of the portfolio, ranked #602.

Benjamin Edwards first reported a position in IDXX in Q4 2021 and has held it in 20 quarters since. The position peaked at $3.01M in Q4 2025. 1,073 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Benjamin Edwards held 3,519 shares of Idexx Laboratories worth $1.84M as of Q3 2026.
  • Benjamin Edwards sold 453 Idexx Laboratories shares in Q3 2026, an estimated $248K.
  • Idexx Laboratories made up 0.02% of Benjamin Edwards's portfolio in Q3 2026, its #602 holding.
  • Benjamin Edwards first reported a position in Idexx Laboratories in Q4 2021 and has held it in 20 quarters since.
  • Benjamin Edwards's Idexx Laboratories position peaked at $3.01M in Q4 2025.
  • 1,073 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.